share_log

康哲藥業：翌日披露報表

CMS: Next Day Disclosure Return

香港交易所 ·  Apr 3 07:26
Summary by Moomoo AI
康哲藥業控股有限公司（CMS）於2024年4月3日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，公司於2024年4月2日及4月3日分別購回2,100,000股及1,470,000股普通股，佔其已發行股份的0.0856%及0.06%。購回後，公司的已發行股本維持不變為2,451,988,512股。2024年4月3日的購回交易，公司共支付了11,018,370港元，每股價格介乎7.41港元至7.59港元。公司秘書吳三燕確認，所有購回均按照香港聯交所的規定進行，並無任何重大變動。自普通決議案通過以來，公司在香港聯交所購回的股份總數為3,570,000股，佔已發行股份的0.1456%。
康哲藥業控股有限公司（CMS）於2024年4月3日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，公司於2024年4月2日及4月3日分別購回2,100,000股及1,470,000股普通股，佔其已發行股份的0.0856%及0.06%。購回後，公司的已發行股本維持不變為2,451,988,512股。2024年4月3日的購回交易，公司共支付了11,018,370港元，每股價格介乎7.41港元至7.59港元。公司秘書吳三燕確認，所有購回均按照香港聯交所的規定進行，並無任何重大變動。自普通決議案通過以來，公司在香港聯交所購回的股份總數為3,570,000股，佔已發行股份的0.1456%。
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON APRIL 3, 2024 DISCLOSING THE STATUS OF ITS SHARE REPURCHASES. According to the report, the company repurchased 2,100,000 shares and 1,470,000 shares of ordinary shares on April 2 and April 3, 2024, respectively, representing 0.0856% and 0.06% of its issued shares. After the repurchase, the issued share capital of the company remained unchanged at 2,451,988,512 shares. In the repurchase transaction on 3 April 2024, the company paid a total of HK$11,018,370 at a price of HK$7.41 to HK$7.59 per share. Company Secretary Wu Sanyan confirmed that all repurchases were carried out in accordance with the rules of the HKEX and there were no significant changes. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the Company on the Hong Kong Stock Exchange is 3,570,000 shares, representing 0.1456% of the issued shares.
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON APRIL 3, 2024 DISCLOSING THE STATUS OF ITS SHARE REPURCHASES. According to the report, the company repurchased 2,100,000 shares and 1,470,000 shares of ordinary shares on April 2 and April 3, 2024, respectively, representing 0.0856% and 0.06% of its issued shares. After the repurchase, the issued share capital of the company remained unchanged at 2,451,988,512 shares. In the repurchase transaction on 3 April 2024, the company paid a total of HK$11,018,370 at a price of HK$7.41 to HK$7.59 per share. Company Secretary Wu Sanyan confirmed that all repurchases were carried out in accordance with the rules of the HKEX and there were no significant changes. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the Company on the Hong Kong Stock Exchange is 3,570,000 shares, representing 0.1456% of the issued shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more